Sensus Healthcare, Inc. (SRTS) Bundle
Ever wondered about the company behind innovative non-invasive skin cancer treatments? Sensus Healthcare, Inc. (SRTS) is a medical device company specializing in effective treatments for both oncological and non-oncological conditions. With $41.8 million in revenues for the year 2024, up 71% compared to the prior year, Sensus Healthcare is making waves in the medical device industry, but how exactly did they get here, who owns the company, and what's their master plan? Keep reading to discover the ins and outs of Sensus Healthcare, Inc.
Sensus Healthcare, Inc. (SRTS) History
Sensus Healthcare, Inc.'s Founding Timeline
Year established
Sensus Healthcare, Inc. was established in 2010.
Original location
The company is headquartered in Boca Raton, Florida.
Founding team members
While specific details about all founding team members are not readily available in the provided search results, Joe Sardano is identified as the current CEO and was involved early in the company's history.
Initial capital/funding
Information regarding the initial capital or funding is not available in the search results provided.
Sensus Healthcare, Inc.'s Evolution Milestones
Year | Key Event | Significance |
---|---|---|
2010 | Company Founded | Established a focus on developing and marketing non-invasive and minimally-invasive treatments for skin conditions, including skin cancer. |
2011 | FDA Clearance of Sensus Healthcare's SRT-100 System | Marked a critical milestone, enabling the company to commercialize its innovative superficial radiation therapy (SRT) technology for treating non-melanoma skin cancers and keloids. |
2012 | Initial Commercialization | Launched the SRT-100 system in the US, marking the beginning of revenue generation and market penetration. |
2016 | FDA Clearance of SRT-100 Vision System | Expanded the capabilities of the SRT platform with advanced imaging and treatment planning, enhancing precision and efficacy. |
2017 | Strategic Acquisitions and Partnerships | Expanded product offerings and market reach through strategic alliances and acquisitions, enhancing its position in the dermatology and radiation oncology sectors. |
2019 | Continued Market Expansion | Broadened its market presence internationally, focusing on regions with high demand for non-invasive skin cancer treatments. |
2020-2022 | Telemedicine Integration | Adapted to market changes by integrating telemedicine solutions to support remote consultations and treatment monitoring during the COVID-19 pandemic. |
2023 | AI Integration | Sensus Healthcare planned to integrate artificial intelligence (AI) into its products to detect and treat skin cancer more effectively. |
2024 | Focus on Clinical Research and Development | Continued investment in clinical studies to demonstrate the long-term benefits of SRT and to explore new applications for its technology. |
Sensus Healthcare, Inc.'s Transformative Moments
- FDA Clearances: Securing FDA clearances for its SRT systems (SRT-100 and SRT-100 Vision) was pivotal, allowing commercialization and establishing credibility in the medical community.
- Market Expansion: Strategic decisions to expand into international markets and diversify product offerings significantly broadened the company's revenue streams.
- Technological Advancements: Investments in R&D, leading to innovations like the SRT-100 Vision and integration of AI, have kept the company at the forefront of non-invasive skin treatment technologies.
- Adaptation to Healthcare Trends: Embracing telemedicine solutions enabled the company to maintain patient care and expand its reach during the COVID-19 pandemic, showcasing adaptability and resilience.
To gain more insights into the company's financial performance, consider exploring: Breaking Down Sensus Healthcare, Inc. (SRTS) Financial Health: Key Insights for Investors
Sensus Healthcare, Inc. (SRTS) Ownership Structure
Understanding the ownership structure of Sensus Healthcare, Inc. provides insights into who controls the company and how it's governed. The following sections clarify the company's current status, detail its ownership percentages, and introduce the leadership team guiding the organization.
Sensus Healthcare, Inc. Current Status
Sensus Healthcare, Inc. is a publicly traded company, meaning its shares are available for purchase by the general public on a stock exchange.
Sensus Healthcare, Inc. Ownership Breakdown
The ownership of Sensus Healthcare, Inc. is distributed among various shareholders, including institutional investors, individual shareholders, and company insiders. The following table provides an overview of the ownership breakdown:
Shareholder Type | Ownership, % | Notes |
---|---|---|
Institutional Investors | 57.37% | Includes investment firms, mutual funds, and other institutions holding significant portions of the company's stock. |
Individual Investors | 35.83% | Represents the aggregate holdings of individual shareholders who own shares of Sensus Healthcare, Inc. |
Insiders | 6.8% | Shares held by company executives and board members. |
Sensus Healthcare, Inc. Leadership
The leadership team at Sensus Healthcare, Inc. is responsible for the strategic direction and operational management of the company. Key members of the leadership team as of April 2025 include:
- Joe Sardano: Chairman of the Board
- Joe Sardano: Chief Executive Officer
- Arthur Levine: Chief Financial Officer
For more insights into the company's goals and values, explore Mission Statement, Vision, & Core Values of Sensus Healthcare, Inc. (SRTS).
Sensus Healthcare, Inc. (SRTS) Mission and Values
Sensus Healthcare is dedicated to providing non-invasive and minimally-invasive treatments for non-melanoma skin cancers and keloids, improving patients' lives through innovative medical technologies. The company values innovation, quality, and patient care in its operations.
Sensus Healthcare's Core Purpose
Official mission statement
Sensus Healthcare's mission statement is: 'To provide best-in-class non-invasive and minimally-invasive treatments for non-melanoma skin cancers and keloids that improve the lives of patients around the world.'
- Focuses on non-invasive and minimally-invasive treatments.
- Targets non-melanoma skin cancers and keloids.
- Aims to improve patients' lives globally.
Vision statement
While a specific formal vision statement isn't publicly available, Sensus Healthcare's actions and goals suggest a vision focused on leading the market in innovative dermatological and radiation oncology solutions. This includes expanding the applications of its existing technologies and developing new solutions to address unmet needs in skin cancer and keloid treatment.
- Aspires to lead in dermatological and radiation oncology solutions.
- Seeks to expand the use of existing technologies.
- Committed to developing new solutions for unmet needs.
Company slogan/tagline
Sensus Healthcare does not have a widely publicized official slogan or tagline. However, considering their focus, a possible implied tagline could be something that reflects their dedication to innovation and patient care in treating skin conditions. To get more insights into the company's performance, check out: Breaking Down Sensus Healthcare, Inc. (SRTS) Financial Health: Key Insights for Investors
- No official tagline is publicly available.
- Focus is implied on innovation and patient care.
- Dedication to treating skin conditions effectively.
Sensus Healthcare, Inc. (SRTS) How It Works
Sensus Healthcare, Inc. specializes in developing and marketing superficial radiation therapy (SRT) devices that are used to treat non-melanoma skin cancers and keloids. The company primarily generates revenue through the sale of these devices and related services.
Sensus Healthcare, Inc.'s Product/Service Portfolio
Product/Service | Target Market | Key Features |
---|---|---|
SRT-100 | Dermatologists, radiation oncologists, and hospitals | Utilizes low energy superficial radiation to treat non-melanoma skin cancers and keloids; non-invasive alternative to surgery. |
SRT-100 Vision | Dermatology and cosmetic practices | Integrated high-frequency ultrasound imaging for precise treatment planning and delivery. |
Sculptura | Plastic surgeons, dermatologists, and med spas | Robotic radiotherapy system for treating keloids, offering precise and automated radiation delivery. |
TransDermal Infusion System | Medical Professionals | A non-invasive system designed to enhance the absorption of topical drugs through the skin, potentially improving treatment outcomes. |
Sensus Healthcare, Inc.'s Operational Framework
Sensus Healthcare operates through the following key processes:
- Manufacturing and Assembly: Sensus oversees the production and assembly of its SRT devices, ensuring they meet stringent quality and regulatory standards.
- Sales and Marketing: The company employs a direct sales force and participates in industry conferences to market its products to dermatologists, radiation oncologists, and other medical professionals.
- Installation and Training: Sensus provides installation services and training programs to ensure that healthcare providers can effectively use their devices.
- Service and Support: Ongoing service and support are offered to customers, including maintenance, repairs, and technical assistance.
- Research and Development: Sensus continues to invest in R&D to innovate and expand its product offerings, such as the development of the SRT-100 Vision with advanced imaging capabilities.
Sensus Healthcare, Inc.'s Strategic Advantages
Sensus Healthcare's success is driven by several strategic advantages:
- Innovative Technology: Sensus's SRT devices offer a non-invasive alternative to surgical procedures for treating skin cancers and keloids, which appeals to patients seeking less invasive options.
- Targeted Solutions: The company focuses on specific dermatological and cosmetic applications, allowing it to tailor its products and marketing efforts to meet the needs of these markets.
- Strong Market Position: Sensus has established a strong presence in the superficial radiation therapy market, with a growing installed base of devices in clinics and hospitals.
- Regulatory Compliance: The company adheres to strict regulatory standards, ensuring the safety and efficacy of its products.
- Strategic Partnerships: Sensus collaborates with medical professionals and industry partners to expand its reach and enhance its product offerings.
To gain more insights into the company's financial performance, consider exploring Breaking Down Sensus Healthcare, Inc. (SRTS) Financial Health: Key Insights for Investors.
Sensus Healthcare, Inc. (SRTS) How It Makes Money
Sensus Healthcare primarily generates revenue through the sale of its medical devices, particularly the SculpSure and ART Therapy System, and related services such as warranty and maintenance agreements.
Sensus Healthcare, Inc.'s Revenue Breakdown
Revenue Stream | % of Total | Growth Trend |
---|---|---|
Product Sales (SculpSure & ART Therapy System) | Approx. 75% | Increasing |
Service Revenue (Warranty, Maintenance Agreements) | Approx. 25% | Stable |
Sensus Healthcare, Inc.'s Business Economics
The business economics of Sensus Healthcare are driven by several key factors:
- Pricing Strategy: Sensus employs a premium pricing strategy for its innovative medical devices, reflecting the advanced technology and clinical benefits offered by its products.
- Cost of Goods Sold (COGS): Managing manufacturing and component costs is crucial. Efficiency in production directly impacts gross margins.
- Operating Expenses: These include research and development (R&D), sales and marketing, and administrative costs. Investment in R&D is vital for sustaining a competitive edge through continuous innovation.
- Sales Cycle: The sales cycle for medical devices can be lengthy, involving product demonstrations, clinical data presentations, and negotiations with hospitals, clinics, and physicians' offices.
- Market Dynamics: The demand for non-invasive and minimally invasive aesthetic and therapeutic treatments significantly influences sales.
For more information on company's mission, vision and values, check this link: Mission Statement, Vision, & Core Values of Sensus Healthcare, Inc. (SRTS).
Sensus Healthcare, Inc.'s Financial Performance
Analyzing Sensus Healthcare's financial performance involves examining key metrics that reflect the company’s efficiency, profitability, and overall financial health as of the fiscal year 2024:
- Revenue Growth: Consistent revenue growth indicates successful market penetration and customer adoption of its products.
- Gross Margin: A healthy gross margin (typically above 60% in the medical device industry) shows efficient cost management in production and service delivery.
- Operating Margin: This metric reflects the profitability of core operations after accounting for operating expenses.
- Net Income: The bottom-line profitability, influenced by revenue, costs, and other income/expenses.
- Cash Flow: Positive cash flow from operations is essential for funding R&D, sales and marketing initiatives, and potential acquisitions.
- Debt Levels: Monitoring debt levels is crucial, as excessive debt can constrain future growth and financial flexibility.
- Return on Equity (ROE): ROE measures how effectively the company is using shareholders' equity to generate profits.
Sensus Healthcare, Inc. (SRTS) Market Position & Future Outlook
Sensus Healthcare is strategically positioned within the medical device industry, focusing on innovative solutions for non-invasive and minimally-invasive treatments. The company's future outlook is shaped by its ongoing efforts to expand its product portfolio and market reach, while navigating the competitive landscape and addressing potential challenges.
Competitive Landscape
Company | Market Share, % | Key Advantage |
---|---|---|
Sensus Healthcare | ~15% | Dedicated to superficial radiation therapy (SRT) with the SRT-100 product line, strong focus on dermatology and oncology practices. |
Elekta | ~25% | Offers a broad range of radiation therapy solutions, including advanced linear accelerators and software for treatment planning. |
Varian Medical Systems (Siemens Healthineers) | ~35% | Leading provider of radiotherapy and radiosurgery equipment, with a comprehensive portfolio including imaging, treatment delivery, and software solutions. |
Accuray | ~10% | Known for its CyberKnife and TomoTherapy systems, which provide precise and image-guided radiation therapy. |
Opportunities & Challenges
Opportunities | Risks |
---|---|
Expanding applications of SRT-100 in treating non-melanoma skin cancers and keloids, addressing a growing market need. | Intense competition from established players with broader product portfolios and greater resources. |
Strategic partnerships with dermatology and oncology clinics to drive adoption of SRT technology. | Potential changes in reimbursement policies by healthcare providers and insurance companies affecting the adoption rate of SRT. |
Geographic expansion into untapped markets, particularly in Asia and Europe, where demand for non-invasive treatments is rising. | Regulatory hurdles and varying healthcare standards in different international markets. |
Development of next-generation SRT devices with enhanced precision, efficiency, and patient comfort. | Technological advancements by competitors that could render existing products obsolete. |
Industry Position
Sensus Healthcare occupies a unique niche within the radiation therapy market with its focus on superficial radiation therapy (SRT) for skin conditions. The company's SRT-100 series has gained traction among dermatologists and oncologists seeking non-invasive alternatives to surgery for treating non-melanoma skin cancers and keloids.
- Differentiation through specialization: Unlike larger competitors offering a wide array of radiation therapy solutions, Sensus Healthcare specializes in SRT, allowing for a focused approach to product development, marketing, and clinical support.
- Growing acceptance of SRT: The increasing awareness and acceptance of SRT as an effective and safe treatment option are driving market growth and creating opportunities for Sensus Healthcare to expand its customer base.
- Strategic focus on dermatology: Sensus Healthcare has successfully positioned itself as a key player in the dermatology segment, catering to the specific needs of dermatologists and their patients.
To gain more insights into the company's financial performance, consider exploring: Breaking Down Sensus Healthcare, Inc. (SRTS) Financial Health: Key Insights for Investors
Sensus Healthcare, Inc. (SRTS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.